Volume 21, Number 6—June 2015
Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries
|Total, N = 1,254||Candidate effective drugs
|Short regimen, FQ-S and SLI-S, n = 952||BDQ-containing regimen
|Combined FQ-R or SLI-R,† n = 302||FQ-R only, n = 73||SLI-R only, n = 155||XDR, n = 74|
*Drug susceptibility test results were analyzed for 7 drugs: high-dose isoniazid, ethambutol, FQ, aminoglycoside, capreomycin, ethionamide, and para-aminosalicylic acid; BDQ, bedaquiline; FQ, fluoroquinolone; R, resistant; S, susceptible; SLI, second-line injectable drug; XDR, extensively drug-resistant.
†Includes FQ-R only, SLI-R only, and XDR cases combined.